| Financial Year |
March 31 2023 |
| Monetary Funds |
48,644,166.16 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
3,600,000.00 |
| Accounts Receivable |
25,613,622.71 |
| Advances to Suppliers |
18,904,033.42 |
| Other Receivables |
271,394.65 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
32,091,735.60 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,484,422.62 |
| Total Current Assets |
130,609,375.16 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
139,720,582.09 |
| Under-construction Projects |
1,433,018.49 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
25,634,985.42 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
582,834.26 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
167,371,420.26 |
| Total Assets |
297,980,795.42 |
| Short-Term Loans |
5,004,323.61 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
20,981,510.45 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,874,367.60 |
| Taxes Payable |
419,024.65 |
| Interest Payable |
-- |
| Dividend Payable |
60,662.40 |
| Other payables |
143,882,904.04 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
1,900,687.13 |
| Sub-Total of Current Liabilities |
194,629,412.72 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,729,827.38 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
10,386,229.86 |
| Total Liabilities |
205,015,642.58 |
| Paid-In Capital(Or Share Stock) |
366,122,195.00 |
| Capital Surplus |
505,305,400.58 |
| Surplus Reserve |
35,087,755.07 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-808,522,462.16 |
| Minority Stockholder's Interest |
16,609,932.89 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
76,355,219.95 |
| Owner's Equity（Stockholder's Equity） |
92,965,152.84 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
297,980,795.42 |
